Crossmark

HIPEC in the Consolidation Setting: A Consolation Prize for Chemorefractory Ovarian Cancer?

Published Online: 2023-02-22

Published Print: 2023-06

Authors

Dellinger, Thanh H.
License Information

Text and Data Mining valid from 2023-02-22

Version of Record valid from 2023-02-22
More Information

Article History

Received: 30 January 2023

Accepted: 6 February 2023

First Online: 22 February 2023

Disclosure

: The author declares no conflicts of interest.

Free to read: This content has been made available to all.

Document is current